Financialnewsmedia.com News Commentary PALM BEACH, Fla., June 2, 2021 /PRNewswire/ Out of all cannabinoids, cannabidiol is most widely used for therapeutic reasons due to the lack of
Share:
Acquisition adds TheraTears brand to Company s leading eye care portfolio
Acquisition expected to add approximately $60 and $20 million of Revenue and EBITDA, respectively on an annual basis
Transaction expected to close during fiscal 2Q
TARRYTOWN, N.Y., May 27, 2021 (GLOBE NEWSWIRE) Prestige Consumer Healthcare Inc. ( Prestige or the Company ) (NYSE:PBH) today announced that it has entered into a definitive agreement to acquire a portfolio of over-the-counter consumer brands from specialty pharmaceutical company Akorn Operating Company LLC ( Akorn ) for $230 million in cash. The agreement is structured as an asset purchase that delivers anticipated tax benefits of ~$30 million and expected annual EBITDA of ~$20 million equating to a transaction valued at less than 10x pro-forma EBITDA. The transaction is estimated to add annual Revenues, Earnings Per Share and Operating Cash Flow of approximately $60 million, $0.10 and $13 million, respectively.
/PRNewswire/ Akorn Operating Company LLC ("Akorn" or the "Company"), a leading specialty pharmaceutical company, announced today that it has entered into a.
managed or advised by Siris Capital Group, LLC)
to be effected by means of a Scheme of Arrangement
under Part 26 of the Companies Act 2006
Summary ·The boards of Equiniti Group plc ( EQ or the Company ) and Earth Private Holdings Ltd ( Bidco ) are pleased to announce that they have agreed the terms of a recommended cash acquisition of EQ by Bidco, a newly-incorporated company indirectly owned by funds managed or advised by Siris Capital Group, LLC ( Siris ) pursuant to which Bidco will acquire the entire issued and to be issued share capital of EQ (the Acquisition ). ·Under the terms of the Acquisition, EQ Shareholders will be entitled to receive: